Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
Piyada Supasa(University of Oxford), Juthathip Mongkolsapaya(Siriraj Hospital), Jose Slon-Campos(Centre for Human Genetics), Neil G. Paterson(Diamond Light Source), Aekkachai Tuekprakhon(Centre for Human Genetics), Guido C. Paesen(Centre for Human Genetics), William James(University of Oxford), Helen M. E. Duyvesteyn(Centre for Human Genetics), Naomi S. Coombes(Public Health England), Sue Charlton(Public Health England), Holly E. Humphries(Public Health England), Eleanor Barnes(Oxford Health NHS Foundation Trust), Paul Klenerman(John Radcliffe Hospital), Elizabeth Clutterbuck(University of Oxford), Thomas S. Walter(Centre for Human Genetics), Helen M. Ginn(Instruct-ERIC), Rungtiwa Nutalai(Centre for Human Genetics), Christina Dold(University of Oxford), Donal Skelly(Virginia Commonwealth University), Daming Zhou(Centre for Human Genetics), Alexander J. Mentzer(Centre for Human Genetics), César López‐Camacho(Centre for Human Genetics), Julian C. Knight(Centre for Human Genetics), Sarah C. Gilbert(University of Oxford), Sheila Lumley(University of Oxford), Andrew J. Pollard(University of Oxford), Alex Sienkiewicz(Public Health England), Sagida Bibi(University of Oxford), Nick Gent, Miles W. Carroll(Centre for Human Genetics), Natalie Baker, Yuguang Zhao(University of Oxford), Sandra Belij‐Rammerstorfer(University of Oxford), Tao Dong(University of Oxford), Elizabeth E. Fry(Centre for Human Genetics), Bassam Hallis(Public Health England), Susanna Dunachie(University of Oxford), Amy Flaxman(University of Oxford), Kevin R. Bewley(Public Health England), Derrick W. Crook(Nuffield Orthopaedic Centre), Imam Shaik(Public Health England), Beibei Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Chang Liu(Centre for Human Genetics), Mark A. Williams(Diamond Light Source), David R. Hall(Diamond Light Source), Robert H. Levin(Worthing Hospital), Wanwisa Dejnirattisai(Centre for Human Genetics), Teresa Lambe(University of Oxford), Kerry Godwin(Public Health England), Mustapha Bittaye(University of Oxford)
Cited by 529
Related Papers
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Global distribution and prevalence of hepatitis C virus genotypes
|Hepatology|2014|1.6k
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections
|Nature Medicine|2002|1.6k